Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Lakewood-Amedex Biotherapeutics Inc. (LABT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Lakewood-Amedex Biotherapeutics Inc. (LABT), most recent 12 months reported: net loss $3.85M. Latest balance sheet on file: liquid cash $4.58M. From SEC filings. Others in Pharmaceutical Preparations: KALA BIO, INC. · KAIROS PHARMA, LTD. · KIORA PHARMACEUTICALS, INC. · PASITHEA THERAPEUTICS CORP. · LB PHARMACEUTICALS INC · Lite Strategy, Inc. · LARIMAR THERAPEUTICS, INC. · LANTERN PHARMA INC.

Stock screener

Watchlist